Read Time:6 Second
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating